BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19560513)

  • 21. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
    van de Kraats C; Killestein J; Popescu V; Rijkers E; Vrenken H; Lütjohann D; Barkhof F; Polman CH; Teunissen CE
    Mult Scler; 2014 Apr; 20(4):412-7. PubMed ID: 23959711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
    Leoni V; Mariotti C; Tabrizi SJ; Valenza M; Wild EJ; Henley SM; Hobbs NZ; Mandelli ML; Grisoli M; Björkhem I; Cattaneo E; Di Donato S
    Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
    Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease.
    Iuliano L; Monticolo R; Straface G; Spoletini I; Gianni W; Caltagirone C; Bossù P; Spalletta G
    J Alzheimers Dis; 2010; 21(4):1383-92. PubMed ID: 21504117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid metabolism in cognitive decline and dementia.
    Panza F; D'Introno A; Colacicco AM; Capurso C; Pichichero G; Capurso SA; Capurso A; Solfrizzi V
    Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole body cholesterol metabolism is impaired in Huntington's disease.
    Leoni V; Mariotti C; Nanetti L; Salvatore E; Squitieri F; Bentivoglio AR; Bandettini di Poggio M; Piacentini S; Monza D; Valenza M; Cattaneo E; Di Donato S
    Neurosci Lett; 2011 May; 494(3):245-9. PubMed ID: 21406216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.
    Costa AC; Joaquim HPG; Nunes VS; Kerr DS; Ferreira GS; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):501-507. PubMed ID: 28861608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.
    Leoni V; Caccia C
    Biochimie; 2013 Mar; 95(3):595-612. PubMed ID: 23041502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
    Zuliani G; Donnorso MP; Bosi C; Passaro A; Dalla Nora E; Zurlo A; Bonetti F; Mozzi AF; Cortese C
    BMC Neurol; 2011 Oct; 11():121. PubMed ID: 21970714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
    Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
    Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
    Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
    Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
    Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.
    Heverin M; Bogdanovic N; Lütjohann D; Bayer T; Pikuleva I; Bretillon L; Diczfalusy U; Winblad B; Björkhem I
    J Lipid Res; 2004 Jan; 45(1):186-93. PubMed ID: 14523054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers.
    Burkard I; von Eckardstein A; Waeber G; Vollenweider P; Rentsch KM
    Atherosclerosis; 2007 Sep; 194(1):71-8. PubMed ID: 17107679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.
    Bretillon L; Sidén A; Wahlund LO; Lütjohann D; Minthon L; Crisby M; Hillert J; Groth CG; Diczfalusy U; Björkhem I
    Neurosci Lett; 2000 Oct; 293(2):87-90. PubMed ID: 11027840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.
    Leoni V; Long JD; Mills JA; Di Donato S; Paulsen JS;
    Neurobiol Dis; 2013 Jul; 55():37-43. PubMed ID: 23557875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
    Holdenrieder S; Lütjohann D; Geiger S; von Bergmann K; Stieber P; Hamann GF
    Neurosci Lett; 2004 Sep; 368(2):201-4. PubMed ID: 15351449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.
    Hughes TM; Kuller LH; Lopez OL; Becker JT; Evans RW; Sutton-Tyrrell K; Rosano C
    J Alzheimers Dis; 2012; 30(1):53-61. PubMed ID: 22377780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
    Baila-Rueda L; Mateo-Gallego R; Jarauta E; de Castro-Orós I; Bea AM; Cenarro A; Civeira F
    Biochem Biophys Res Commun; 2014 Apr; 446(3):731-5. PubMed ID: 24406166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
    Novakova L; Axelsson M; Malmeström C; Zetterberg H; Björkhem I; Karrenbauer VD; Lycke J
    J Neurol Sci; 2015 Nov; 358(1-2):201-6. PubMed ID: 26342940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.